Catherine A. Billups

发表

Initial testing (stage 1) of the phosphatidylinositol 3′ kinase inhibitor, SAR245408 (XL147) by the pediatric preclinical testing program

S. Keir, J. Maris, P. Houghton, 2013, Pediatric blood & cancer.

Initial testing (stage 1) of the polo‐like kinase inhibitor volasertib (BI 6727), by the Pediatric Preclinical Testing Program

S. Keir, J. Maris, P. Houghton, 2014, Pediatric blood & cancer.

Telangiectatic osteosarcoma: The St. Jude Children's Research Hospital's experience

N. Daw, F. Hoffer, Jianrong Wu, 2007, Cancer.

Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicity

T. Merchant, C. Rodríguez-Galindo, R. Brennan, 2012, Cancer.

Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high‐risk sarcomas

T. Merchant, A. Pappo, S. Spunt, 2006, Cancer.

The impact of early resection of primary neuroblastoma on the survival of children older than 1 year of age with stage 4 disease

A. Davidoff, C. Fuller, L. McGregor, 2005, Cancer.

Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing program

S. Keir, J. Maris, P. Houghton, 2009, Pediatric blood & cancer.

Intensity modulated radiation therapy provides excellent local control in high‐risk abdominal neuroblastoma

A. Davidoff, L. McGregor, W. Furman, 2013, Pediatric blood & cancer.

Initial testing (stage 1) of LCL161, a SMAC mimetic, by the pediatric preclinical testing program

S. Keir, J. Maris, P. Houghton, 2012, Pediatric blood & cancer.

Analysis of Prognostic Factors in Extraosseous Ewing Sarcoma Family of Tumors: Review of St. Jude Children’s Research Hospital Experience

A. Davidoff, F. Navid, M. Krasin, 2012, Annals of Surgical Oncology.

Initial testing of lenalidomide by the pediatric preclinical testing program

S. Keir, J. Maris, P. Houghton, 2011, Pediatric blood & cancer.

Outcome after local recurrence of osteosarcoma

C. Rodríguez-Galindo, N. Daw, M. B. McCarville, 2004, Cancer.

Initial testing (stage 1) of SGI‐1776, a PIM1 kinase inhibitor, by the pediatric preclinical testing program

S. Keir, J. Maris, P. Houghton, 2012, Pediatric blood & cancer.

Efficacy of combined surgery and irradiation for localized Ewings sarcoma family of tumors

T. Merchant, A. Davidoff, C. Fuller, 2004, Pediatric blood & cancer.

Clinical features and outcomes of young patients with head and neck non‐rhabdomyosarcoma soft tissue sarcomas

Sara M. Federico, S. Spunt, S. Samant, 2015, Head & neck.

Predictive factors of invasion in eyes with retinoblastoma enucleated after eye salvage treatments

C. Rodríguez-Galindo, J. Khoury, J. Balaguer, 2009, Pediatric blood & cancer.

Evaluation of arsenic trioxide by the pediatric preclinical testing program with a focus on Ewing sarcoma

P. Houghton, J. Toretsky, Min H. Kang, 2012, Pediatric blood & cancer.

Timing of Surgery and the Role of Adjuvant Radiotherapy in Ewing Sarcoma of the Chest Wall: A Single-institution Experience

A. Davidoff, F. Navid, M. Krasin, 2012, Annals of Surgical Oncology.

Initial testing (stage 1) of glembatumumab vedotin (CDX‐011) by the pediatric preclinical testing program

P. Houghton, R. Gorlick, C. Billups, 2014, Pediatric blood & cancer.

Combination testing of cediranib (AZD2171) against childhood cancer models by the pediatric preclinical testing program

S. Keir, J. Maris, P. Houghton, 2012, Pediatric blood & cancer.